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Our understanding of immunity to fungal pathogens has advanced considerably in recent years. Particularly
significant have been the parallel discoveries in the C-type lectin receptor family and the Th effector arms of
immunity, especially Th17 cells and their signature cytokine, IL-17.Many of these studies have focused on the
most common human fungal pathogen, Candida albicans,which is typically a commensal microbe in healthy
individuals but causes various disease manifestations in immunocompromised hosts, ranging from mild
mucosal infections to lethal disseminated disease. Here, we discuss emerging fundamental discoveries
with C. albicans that have informed our overall molecular understanding of fungal immunity. In particular,
we focus on the importance of pattern recognition receptor-mediated fungal recognition and subsequent
IL-17 responses in host defense against mucosal candidiasis. In light of these recent advances, we also
discuss the implications for anticytokine biologic therapy and vaccine development.Introduction
It is estimated that 1.5 million fungal species populate the planet,
but only a few hundred establish infection in humans, and an
even smaller number reside as commensals (Hube, 2009).
However, in the rare situations where they cause disease, fungal
infections are associated with significant morbidity and mortality
and can be difficult to diagnose in a clinically relevant time frame.
To date, there are no vaccines against any fungal organisms,
so it is imperative to understand the intricate host-pathogen
relationships between humans and fungi.
Until recently, little was known about the mechanisms by
which the innate immune system recognizes fungal pathogens
or the subsequent development of pathogen-specific adaptive
immune responses. Two major concepts in recent years have
significantly impacted our understanding of fungal immunity.
First, the discovery of C-type lectin receptors (CLRs) as recog-
nition elements for fungi shed light on the innate mechanisms
of rapid antifungal responses. Second, the discovery of Th17
cells as a distinct T helper cell population set the stage for
discoveries revealing a key role for this new T cell subset in anti-
fungal immunity. In this review, we will discuss CLRs and other
relevant pattern recognition receptors (PRRs) in innate fungal
recognition and the subsequent activation of Th17-based adap-
tive immunity. We will focus on these responses primarily in the
context of the most common and best-characterized human
fungal pathogen, Candida albicans, although lessons learned
from this organism may well be applicable to other fungal path-
ogens.
Pattern Recognition of Candida albicans: TLRs and
Beyond
As attested by the 2011 Nobel Prize in Medicine or Physiology,
the concept of ‘‘pattern recognition’’ by the innate immune
system fundamentally altered our view of how microbes are
recognized at the molecular level, and ultimately how adaptive
responses are shaped by this recognition. Toll-like receptors
(TLRs) were the first such PRRs to be recognized, but new
studies have shed valuable light on how other molecules suchCLRs and the inflammasome detect microbes and subsequently
direct skewing of Th cell responses.
Most fungal PRRs recognize components of the C. albicans
cell wall, which is a complex array of layered proteins and carbo-
hydrates (Gow et al., 2012) (Figure 1). Candida albicans is
a dimorphic fungus, existing in yeast (conidia) or hyphal (filamen-
tous) forms. The outer portion of the Candida cell wall is largely
composed of mannan and manoproteins, and the inner layer is
composed of b-(1,3)-glucan and chitin moieties. Expression of
cell wall proteins and carbohydrates is significantly altered
during the yeast to hyphal transition, which occurs when the
fungus invades target organs. The immune system, by virtue of
distinct PRRs, can distinguish these fungal forms, in ways that
are beginning to be unraveled. Accumulating evidence demon-
strates that PRR engagement by C. albicans in antigen-present-
ing cells (APCs) results in secretion of specific cytokines
including IL-1b, IL-23, and IL-6 (Gow et al., 2012; Netea et al.,
2008a; Romani, 2011). These cytokines in turn promote skewing
of activated CD4+ T cells into the Th17 lineage, which express
IL-17 (also known as IL-17A), IL-17F, and IL-22. IL-17 and IL-
17F are closely related cytokines that signal through a common
receptor (composed of the IL-17RA and IL-17RC subunits), and
IL-17R signaling is clearly crucial for effective anti-Candida
immunity (Conti and Gaffen, 2010) (Figure 2). The importance
of the IL-17/Th17 pathway is also borne out in humans, as dis-
cussed in more detail in subsequent sections (see Table 1).
Toll-like Receptors
Of the Toll-like receptors, TLR2 and TLR4 are the major partici-
pants in C. albicans recognition. TLR2 binds to phospholipo-
mannans and b-glucan (the major component of yeast zymosan)
and acts in combination with dectin-1 to induce proinflammatory
responses in a variety of Candida infection settings (Hise et al.,
2009; Netea et al., 2006; Villamo´n et al., 2004; Yuan and Wilhel-
mus, 2010) (Figures 1 and 2A). TLR2 has also been shown to
suppress inflammatory responses to Candida via production of
IL-10 and enhanced T regulatory cell (Treg) survival. Accordingly,
TLR2/ mice are more resistant to disseminated candidiasis
than the WT, supporting a detrimental rather than protectiveCell Host & Microbe 11, May 17, 2012 ª2012 Elsevier Inc. 425
Figure 1. The Candida Cell Wall and PRRs that Recognize Subcomponents Thereof
The yeast cell wall is composed of a variety of proteins and carbohydrates that serve as pathogen-associatedmolecular patterns (PAMPs). These are recognized
by PRRs in host cells and consequently induce inflammatory immune responses. The skeleton or the inner portion of the cell wall is mainly composed of chitin and
b-(1,3)-glucan. Whereas b-(1,3)-glucan is recognized by Dectin-1, the receptor for chitin remains to be identified. The outer portion of the cell wall is comprised
of mannoproteins and mannan, which are recognized by TLR4 and CLRs such as dectin-2, mincle and the mannose receptor. Engagement of appropriate PRRs
by these cell wall molecular moieties results in the production of cytokines that shape antifungal immune responses.
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recognizes C. albicans O-linked mannan and stimulates pro-
duction of the inflammatory cytokine TNFa in human mononu-
clear cells and murine macrophages. TLR4/ mice exhibited
increased susceptibility to disseminated candidiasis (Netea
et al., 2002). Although TLR9, TLR1, and TLR6 are also implicated
in recognizing Candida pathogen-associated molecular patterns
(PAMPs), none are required for immunity to this organism (Netea
et al., 2008b; van de Veerdonk et al., 2008). Mice deficient in
MyD88, an adaptor central to TLR signaling, are sensitive to
Candida infection, which supports a role for either TLRs or alter-
natively IL-1 family cytokines (Bellocchio et al., 2004). However,
humans with MyD88 defects do not appear to be particularly
prone to fungal infections (von Bernuth et al., 2008). Thus, other
pathways of pattern recognition are important in C. albicans
immune sensing and the subsequent priming of T helper cell
responses. Alternatively, this paradox may indicate a difference
in how mice and humans sense this organism.
C-type Lectin Receptors
The CLRs have garnered considerable attention in the context of
Candida, and appear to be comparatively more critical than
TLRs for immunity in both mouse models and humans (Saijo
and Iwakura, 2011; Vautier et al., 2010). The best-characterized
CLRs with respect to Candida are dectin-1, dectin-2, and mincle
(Figure 1, 2A). Although details of their respective signaling path-
ways are still being elucidated, they all appear to mediate
signaling through the kinase Syk1, the adaptors CARD9/Bcl-
10/MALT1, and the NF-kB and Ras/Raf-1 pathways (Gow
et al., 2012; Willment and Brown, 2008). Dectin-2 and Mincle
form heteromeric complexes with the FcgR, whereas dectin-1
does not engage this subunit. Recently, the kinase PKCd was426 Cell Host & Microbe 11, May 17, 2012 ª2012 Elsevier Inc.shown to be activated by dectin-1 and induce phosphorylation
of CARD9. Both CARD9/ and PKCd/ mice are susceptible
to disseminated candidiasis (LeibundGut-Landmann et al.,
2007; Strasser et al., 2012). The CLR DC-SIGN in human
dendritic cells (DCs) is involved in mediating Candida uptake
via recognition of N-linkedmannan (Cambi et al., 2008; Takahara
et al., 2012). Although the role of DC-SIGN in the generation of
Th17 responses duringC. albicans infection is unclear, it appears
to inhibit dectin-1-dependent Th17 generation and instead favor
Th1 responses in a model of tuberculosis (Zenaro et al., 2009).
Similarly, the lectin Galectin 3 also recognizesCandida (reviewed
in Brown, 2010; Gow et al., 2012; Netea et al., 2008a). Although
the specific contribution of this receptor to antifungal immunity
is not well defined, a recent study showed that Galectin 3
associates with dectin-1 and contributes to TNFa production
in macrophages (Esteban et al., 2011). Exactly how signals
from these disparate CLRs are integrated is still not fully under-
stood.
Dectin-1 recognizes the b-(1,3)-glucan, which is usually buried
underneath a layer of cell wall proteins and mannan moieties,
posing an issue of accessibility for innate immune cells. Never-
theless, b-glucan is exposed in bud scars that are revealed
during the process of hyphal transition, which facilitates its
recognition and may be the essential signal that alerts the host
of a transition from fungal colonization to infection (Netea
et al., 2008a). Consistently, dectin-1-deficient mice exhibit
impaired production of inflammatory cytokines such as IL-6
and granulocyte colony-stimulating factor (G-CSF) (Taylor
et al., 2007), which drive Th17 differentiation and are induced
upon IL-17 signaling (Gaffen, 2009) (Figure 2B). Furthermore,
b-glucan stimulation of bone marrow-derived dendritic cells
Figure 2. PRR and Th17-Based Immunity to Candida albicans
(A) PRRs including CLRs (dectin-1, dectin-2, mincle), TLRs (TLR2, TLR4) and inflammasomes (NLRP3, NLRC4, Caspase-8) respond to Candida PAMPs by
inducing the NF-kB and MAPK pathways.
(B) PRRs in turn trigger expression and secretion of IL-6, IL-23, and IL-1b, which induce Th17 differentiation via the transcription factors STAT3 and RORgt.
(C) IL-17A and IL-17F produced by Th17 cells act on epithelial and mesenchymal cells to induce expression of neutrophil attracting chemokines (IL-8, CXCL1,
CXCL5) and G-CSF, as well as AMPs such as defensins and S100 proteins.
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ing CLR signaling and activation of a Th17 response (Lei-
bundGut-Landmann et al., 2007).
However, the role of dectin-1 in fungal host defense remains
a topic of debate. Whereas one study showed that dectin-1/
mice showed increased susceptibility to disseminated candidi-
asis (Taylor et al., 2007), another report found that dectin-1/
mice were resistant (Saijo et al., 2007). Intriguingly, in the
study by Saijo et al., dectin-1/ mice were susceptible to
Pneumocystis carinii, suggesting that the role of dectin-1 in anti-
fungal immunity may be pathogen specific. In addition to
promoting Th17 responses, dectin-1 signaling appears to play
a role in balancing the frequencies of Th1 and Th17 cells. Specif-
ically, the absence of dectin-1 during lung infection with
Aspergillus fumigatus causes reduced production of IFNg and
T-bet, a transcription factor that controls Th1 differentiation,
resulting in decreased Th1 responses and correspondingly
enhanced Th17 differentiation (Rivera et al., 2011). Therefore,
b-glucan recognition by dectin-1 shapes the overall nature of
antifungal CD4+ T helper responses. As described in detail
below, dectin-1-deficient humans with chronic mucocutaneous
candidiasis (CMC) have been identified, supporting the idea
that dectin-1 is a bona fide recognition element for Candida(Table 1). However, disease in these patients was generally
mild, and the mutation was later found to be a fairly common
polymorphism linked to Candida colonization in transplant
recipients (Plantinga et al., 2009). Thus, PRRs other than dec-
tin-1 probably play central roles in immunity to Candida.
Dectin-2 recognizes N-linked mannan sugars, which are
localized in the exterior layer of the yeast cell wall (Robinson
et al., 2009), and appears to be especially important in recogni-
tion of hyphae (Bi et al., 2010). Similar to dectin-1, stimulation of
BMDCs via dectin-2 triggers Th17 differentiation. C. albicans-
specific Th17 cells are diminished more dramatically in the
absence of dectin-2 than in the absence of dectin-1 (Robinson
et al., 2009). However, not all studies of dectin-2 in antifungal
host defense are consistent. One report showed that antibody
blockade of dectin-2 in dectin-1/ mice led to reduced IL-17
production during systemic Candida infections. Surprisingly,
however, diminished IL-17 production did not correlate with
disseminated disease as assessed by kidney fungal burden
(Robinson et al., 2009). In contrast, dectin 2/mice were found
to be more susceptible to disseminated candidiasis than WT
mice (Saijo et al., 2010). The basis for these discrepancies was
attributed to different observation periods and disease kinetics,
but it may also indicate that additional elements are involved inCell Host & Microbe 11, May 17, 2012 ª2012 Elsevier Inc. 427
Table 1. Human Genetic Deficiencies Associated with Candidiasis and IL-17
Gene Product Disease Impact on Th17/IL17 References
Dectin-1 CMC Reduced frequency of Th17 cells Ferwerda et al. (2009)
CARD9 CMC; disseminated
candidiasis
Impaired dectin-1 (and dectin-2/mincle?)
signaling; reduced frequency of Th17 cells
Glocker et al. (2009)
STAT3 Autosomal dominant Hyper
IgE (Job’s) Syndrome (CMC)
Impaired IL-6/IL-21/IL-22/IL-23 signaling;
reduced frequency of Th17 cells
Ma et al. (2008);
Milner et al. (2008)
TYK2 Autosomal recessive Hyper
IgE (Job’s) Syndrome (CMC)
Defective IL-23 signaling; reduced
Th17 frequency
Minegishi et al. (2006)
IL-17RA CMC Complete IL-17RA deficiency; abolished
responses to IL-17A/IL-17F
Puel et al. (2011)
IL-17F CMC Impaired signaling through IL-17A/IL-17F Puel et al. (2011)
STAT1 CMC Increased responses to IFNa/b, IFNg,
and IL-27; reduced Th17 frequency
Liu et al. (2011); van de
Veerdonk et al. (2011b)
AIRE Autoimmune
Polyendocrinopathy
Syndrome-1 (CMC)
Neutralizing autoantibodies against
IL-17A, IL-17F, and IL-22
Kisand et al. (2010);
Puel et al. (2010)
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different components of the Candida cell wall and thus may
preferentially ‘‘see’’ yeast versus hyphal forms of the microbe,
in vivo studies have not yet fully clarified which CLR is more
important. Ultimately, it is likely that signaling through a multi-
plicity of PRRs is needed to develop an optimal immune
response.
In addition to dectins, mincle and the mannose receptor (MR)
recognize mannan carbohydrates from Candida (Figure 1). In
human peripheral blood mononuclear cells (PBMCs), mannan
was found to induce more IL-17 than other fungal PAMPs such
as b-glucan and chitin (van de Veerdonk et al., 2009), perhaps
indicating a dominant role for MR in this process. Interestingly,
this study also demonstrated MR-dependent production of
IL-17 in cells from dectin-1-deficient patients, supporting the
idea that stimulation of MR byC. albicans is potentially a primary
pathway for the generation of antigen-specific Th17 responses.
Mincle binds to the mycobacterial component Trehalose-6,6-
dimycolate (TDM) and its synthetic analog Trehalose-6,
6-dibehenate (TDB), and it induces Th1 and Th17 responses in
a Syk- and CARD9-dependent manner (Ishikawa et al., 2009;
Schoenen et al., 2010; Werninghaus et al., 2009). This suggests
that fungal cell wall components such as a-mannansmay induce
Th17 responses via mincle. Interestingly, whereas mincle-
deficient mice are susceptible to disseminated candidiasis
(Wells et al., 2008), MR-deficient mice are resistant (Lee et al.,
2003), arguing that the MR is redundant with CLRs in terms of
mediating anti-Candida immunity.
The Inflammasome
The intracellular inflammasome has emerged as another PRR
in antifungal host defense. Composed of cytosolic Nod-like
receptors (NLRs), notably NLRP1, NLRP3, and NLRC4, com-
plexed with several adaptors and proteases, the inflammasome
activates caspase-1 and thereby permits cleavage and secretion
of the proinflammatory cytokines IL-1b and IL-18. While neither
the cytosolic receptors NOD1 nor NOD2 are required for
Candida recognition (van der Graaf et al., 2006), inflammasomes
are involved. Mice deficient in the IL-1 receptor (IL-1R) or
apoptosis-associated speck-like protein (ASC), an essential428 Cell Host & Microbe 11, May 17, 2012 ª2012 Elsevier Inc.subunit of the inflammasome, exhibit increased oral fungal
burdens in a model of oral mucosal candidiasis (Hise et al.,
2009). Fungal dissemination in this model was even more
pronounced than mucosal infection. Consistent with this
concept, NLRP3/mice are susceptible to disseminated candi-
diasis as well as mucosal disease (Gross et al., 2009). Elegant
bone marrow chimera experiments confirmed the role of the
NLRP3 inflammasome in preventing Candida dissemination
and further demonstrated that the NLRC4 inflammasome
compartment was also involved in oral C. albicans host infec-
tions (Tomalka et al., 2011). Notably, NLRP3 is required in
hematopoietic cells, whereas NLRC4 functions at the level of
the mucosal stroma. Moreover, both NLRP3 and NLRC4
deficiencies resulted in decreased expression of IL-17, IL-17F,
and one of the IL-17 receptor subunits (IL-17RA), directly linking
the inflammasomes and IL-17 (Tomalka et al., 2011). Further-
more, BMDCs from ASC/ and caspase-1/ mice exhibited
impaired production of IL-1b and IL-18 after Candida exposure,
which are important for Th17 and Th1 development, respec-
tively. Indeed, splenocytes from IL-1b- and IL-18-deficient
mice exhibited impaired production of IL-17 and IFNg in
response to stimulation from Candida (van de Veerdonk et al.,
2011a). The development of protective Th17 responses via in-
flammasome activation resulted from the recognition of
C. albicans hyphae by human macrophages. The yeast form
did not activate the inflammasome, demonstrating that this
pathway is likely important for discriminating between colonizing
yeast and invasive hyphae (Cheng et al., 2011).
In addition to the role of the NLRP3 and NLRC4 inflamma-
somes in processing pro-IL-1b, a recent study identified
dectin-1-dependent activation of a noncanonical caspase-8
inflammasome (Gringhuis et al., 2012). Dectin-1 engagement
resulted in the activation of Syk and the transcription of the il1b
gene through the CARD9-Bcl10-MALT1 complex (Figure 2B).
Recruitment of MALT1-caspase-8 and ASC to this scaffold
resulted in processing of pro-IL-1b to mature IL-1b. The activa-
tion of this noncanonical pathway did not require C. albicans
internalization, whereas activation of NLRP3 inflammasome was
completely dependent on internalization. Interestingly, some
Cell Host & Microbe
ReviewC. albicans strains trigger IL-1b production primarily via cas-
pase-8 while others also activate the NLRP3 inflammasome,
suggesting that the ligand for NLRP3 is not present in all fungi.
It would be of interest to determine the role of the caspase-8 in-
flammasome in the development of Th17 responses, but that
was not addressed in this study.
Taken together, the priming of host-protective Th17
responses is likely a combined effort of multiple PRR pathways
that recognize different components of C. albicans and trigger
the production of cytokines that predominantly direct Th17
differentiation. Nuances of how different fungal PAMPS trigger
different PRRs is an area that requires more development, and
subtle alterations of the host response may ensue depending
on the specific substrain of Candida that is involved and the
anatomic site of infection.
Antifungal Cell-Mediated Immunity: Life before Th17
A dramatic illustration of the importance of cell-mediated immu-
nity to C. albicans came from the AIDS pandemic. HIV+ individ-
uals are exquisitely susceptible to many opportunistic fungal
pathogens, including oral thrush caused mainly by C. albicans
(Klatt and Brenchley, 2010). Development of opportunistic infec-
tions in AIDS trackswith loss of CD4+ T lymphocytes, implicating
that cytokines produced by CD4+ T cells are important in immu-
nity to Candida (Glocker and Grimbacher, 2010). Studies in 1995
to probe CD4 immunity in mucosal candidiasis employed
a mouse model of gastric Candida infection. In this setting,
both IFNg- and IL-5-producing CD4+ T cells, indicative of Th1
and Th2, respectively, were found in Peyer’s Patches and
mesenteric lymph nodes, and corresponded with fungal clear-
ance. Furthermore, neutralization of IL-4 resulted in increased
IFNg production and enhanced yeast clearance (Cenci et al.,
1995). These data were interpreted to mean that protective anti-
fungal immunity is attributable to Th1 cells, even though hallmark
cytokines of both Th1 and Th2 lineages were produced during
infection (Cenci et al., 1995, 1998). Since these studies occurred
prior to the recognition of the Th17 population, the alternative
interpretation that non-Th1/Th2 lineages might be involved was
not considered.
Studies in a mouse model of oropharyngeal candidiasis
(OPC, ‘‘thrush’’) showed that nude (T cell-deficient) mice were
susceptible to infection, but could be protected by transfer
of CD4+ T cells (Farah et al., 2002). Th1-related cytokines,
including IFNg and TNFa, but not Th2 cytokines were ex-
pressed in the oral tissue, consistent with a Th1-biased re-
sponse. Interestingly, however, depletion of CD4 or CD8
T cells in a susceptible mouse strain did not exacerbate oral
colonization with Candida (Ashman et al., 2003), although adop-
tive transfer of Candida-specific T cells did induce protection
from a disseminated challenge (Sieck et al., 1993). Thus, both
innate cells and CD4 cells were implicated in immunity to
OPC, although the specific subset and cytokines were still not
well clarified.
Antifungal Cell-Mediated Immunity: Life after Th17
The Th1/Th2 paradigm was first described in 1986, and immune
responses, whether infectious or autoimmune, were pigeon-
holed into these categories for nearly two decades. Over time,
it became clear that this model was fraught with discrepancies.A central paradox was that the signature Th1 effector cytokine,
IFNg, was significantly less important in various disease settings
than was IL-12, the key Th1 inductive cytokine (Steinman, 2007).
A significant overhaul in the prevailing paradigm of CD4-
mediated immunity occurred with the discovery of Th17 cells,
which reconciled many of these discrepancies. Of particular
importance were the findings that (1) IL-23 promotes IL-17
expression in T cells (Aggarwal et al., 2003) and (2) the p40
subunit of IL-12 is sharedwith IL-23 and the IL-12Rb1 is a subunit
of the IL-23R (Ghilardi and Ouyang, 2007). Thus, mice lacking
either IL-12p40 or IL-12Rb1 are deficient not only in IL-12 (hence,
lacking Th1 cells), but also IL-23 (hence, lacking Th17 cells).
Subsequent studies showed that Th17 cells arise from inductive
signals from TGFb, IL-6, and IL-1b, while IL-23 is an essential
maintenance and pathogenic factor for Th17 cells (McGeachy
and Cua, 2007; Stockinger and Veldhoen, 2007).
The application of this concept to Candida albicans immunity
has developed over the last several years. A role for the IL-17
axis in antifungal host defense was first shown in 2004, in which
IL-17 receptor (IL-17R)-deficient mice inoculated i.v. with
C. albicans exhibited decreased survival and increased kidney
fungal burden compared to WT counterparts (Huang et al.,
2004). Although disputed in one report (De Luca et al., 2010),
most data are consistent with a protective role for IL-17 in
systemic candidemia (Huang et al., 2004; van de Veerdonk
et al., 2010). Furthermore, an experimental vaccine containing
the C. albicans adhesin protein Als3p and aluminum hydroxide
as an adjuvant conferred protection against systemic candidi-
asis via induction of both Th17 and Th1 responses (Lin et al.,
2009).
In amodel of OPC,mice lacking Th1 effector cytokines IFNg or
TNFa were resistant to oral infection, yet mice lacking IL-12p40
were found to be susceptible (Farah et al., 2006). Since IL-12p40
is shared by IL-12 (p40/p35) and IL-23 (p40/p19) (Oppmann
et al., 2000), this finding hinted at a role for protective IL-23-
dependent rather than IL-12-dependent pathways. In a direct
test of this hypothesis, IL-23p19/ mice subjected to OPC ex-
hibited overt thrush lesions and elevated fungal burdens
whereas IL-12p35/ mice did not. High susceptibility was also
observed in IL-17RA/ and IL-17RC/ mice, implicating the
IL-17 pathway directly (Conti et al., 2009; Ho et al., 2010)
(Figure 2C). Furthermore, in extended time courses, IL-17R/
mice never recovered from Candida infection, whereas IL-
12p35/ mice fully cleared the microbe, albeit delayed
compared to WT mice.
Parallel findings were made in mouse models of dermal candi-
diasis, in which IL-17 and IL-23 but not IL-12 were essential
for immunity to Candida (Kagami et al., 2010). A detailed study
of skin-resident DC subsets showed that Th17 cells against
Candida are generated specifically by presentation from Lang-
erhans cells. Interestingly, generation of Th17 cells is blocked
by signals from Langerin+ dermal DCs in favor of Th1 cells
(Igya´rto´ et al., 2011). In a vaginal candidiasis model, treating
with halofuginone, which specifically blocks Th17 differentia-
tion, resulted in a profound decrease in IL-17 production that
correlated with an increase in fungal burden (Pietrella et al.,
2011). Thus, similar to disseminated candidemia, mouse models
of skin and mucosal candidiasis implicate IL-17 and IL-23 in
immunity to Candida.Cell Host & Microbe 11, May 17, 2012 ª2012 Elsevier Inc. 429
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between Th17 cells and Tregs, a subset of immunoregulatory
T cells, suggesting both are required for effective host responses
to Candida. Th17 and Treg cells both arise from signals from
TGFb (although this is still somewhat controversial [Ghoreschi
et al., 2010]), with IL-6 and IL-1b providing the inflammatory
switch that favors Th17 cells, and IL-2 driving Tregs and prevent-
ing Th17 differentiation (Laurence et al., 2007; Yang et al., 2011).
Rag/ mice, which lack both T and B cells, are extremely
susceptible to OPC. However, transfer of naive or Th17-
polarized T effector cells alone is insufficient to mediate host
defense to OPC; rather, cotransfer of regulatory T cells resulted
in enhanced Th17 responses that were needed to prevent devel-
opment of OPC. Mechanistically, this was shown to be due to
a sequestration of IL-2 by Tregs via the high affinity IL-2 receptor
complex. Consistently, depletion of Tregs in mice increases
susceptibility to OPC (Pandiyan et al., 2011). This finding is in
agreement with an earlier report that demonstrated a positive
correlation between the levels of IL-17 produced by curdlan-
stimulated BMDCs and the ratio of Treg to T effector cells (Lei-
bundGut-Landmann et al., 2007). Interestingly, stimulation of
BMDCs with curdlan triggered conversion of Foxp3+IL-17– cells
into IL-17-expressing Foxp3+ cells (Osorio et al., 2008), sug-
gesting that dectin-1 enhances a Th17 response by converting
Tregs. Thus, Tregs play a previously unappreciated protective
role in inflammatory responses during C. albicans infection.
Intriguingly, C. albicans appears to actively target the IL-17
pathway, presumably as an evasive strategy. Whereas heat-
killed Candida stimulated PBMCs secrete IL-17, coculture with
live Candida strongly suppresses IL-17 production. This factor
is apparently soluble (and thus far, unidentified), because live
Candida exerted this suppressive effect even when separated
from PMBCs in a transwell system. The mechanism appears to
be via regulation of tryptophan metabolism. Specifically,
suppression of IL-17 observed in coculture was associated
with reduced L-kynurenine (an indoleamine 2,3-dioxygenase
[IDO]-dependent metabolite, representing one pathway of
tryptophan metabolism) and increased 5-hydroxytryptophan
(representing the alternate pathway). Consistently, ectopic
application of 5-hydroxytryptophan inhibited IL-17 production
(Cheng et al., 2010). Another recent report suggests that IL-17
might directly bind to Candida and induce nutrient starvation
conditions in the organism (Zelante et al., 2012). Thus, there is
still much to learn about the intricate interactions occurring
between Candida and its host.
In addition to IL-17A, other Th17-derived cytokines such as
IL-17F and IL-22 may also participate in anti-Candida immunity.
In contrast to IL-17A/ mice, IL-17F knockouts are resistant to
systemic candidiasis (Saijo et al., 2010), although the role of
IL-17F in experimental mucosal candidiasis has not yet been
evaluated. As noted in Table 1, dominant negative mutations in
il17f in humans are linked to CMC, although the mutations affect
IL-17A as well as IL-17F signaling (Puel et al., 2011). Surprisingly,
IL-22/ mice inoculated orally with C. albicans had a signifi-
cantly lower fungal burden than IL-17RA/ or IL-23/ mice,
despite the observation that IL-22 mRNA is strongly induced
in WT mice after oral Candida infection (Conti et al., 2009).
Similarly, in dermal candidiasis there was no major role for IL-
22 (Kagami et al., 2010). However, De Luca et al. reported that430 Cell Host & Microbe 11, May 17, 2012 ª2012 Elsevier Inc.IL-22/ mice are susceptible to both systemic and gastric
candidiasis, due in part to impaired production of antimicrobial
peptides (AMPs) such as S100A8, S100A9, RegIIIb, and RegIIIg.
In addition, blockade of IFNg in IL-22/ mice resulted in fungal
dissemination, suggesting that IL-22 together with IFNg may
provide a first line of defense in preventing dissemination from
the gastric mucosa (De Luca et al., 2010). In a recent study in
which human keratinocytes were infected in vitro with
C. albicans, IL-22 in combination with TNFa led to decreased
cell death and epidermal damage caused by infection (Eyerich
et al., 2011). Moreover, IL-22 is impaired in several human
CMC syndromes (Table 1), and thus its role in human candidiasis
cannot be ruled out.
Most of the studies in experimental candidiasis have
described a protective role for IL-17 in host responses to C. albi-
cans. However, a detrimental role of this cytokine has also been
reported, specifically in a model of gastric candidiasis. IL-
23p19/ and IL-12/IL-23p40/mice inoculated intragastrically
with C. albicans showed 100% survival over a 2 week period,
whereas only 25% of IL-12p35/ mice survived. Furthermore,
expression of IL-12p70 and IFNg in stomach correlated with
protection in IL-23/ mice, whereas levels of IL-23p19 and IL-
17 were linked to severity of disease (Zelante et al., 2007).
Candida does colonize the gut, but the clinical relevance of the
gastric candidiasis disease model is unclear. Although some
cases of gastric candidiasis have been reported, they are
extremely rare due to the low pH and inhospitable conditions
of the stomach (Filler, 2012). Regardless, these studies indicate
that lessons of immunity in the gutmucosa cannot necessarily be
applied to other sites.
Experiments of Nature: IL-17 andCandidiasis in Humans
The identification of Th17 cells and CLRs as elements of anti-
fungal immunity facilitated characterization of human genetic
deficiencies underlying development of CMC, either in isolation
(CMC disease) or in the context of an immune disorder (Table
1). The most direct link of IL-17 to the etiology of CMC disease
comes from a recent report describing rare human pedigrees
with mutations in the IL-17 signaling axis. One individual had
an autosomal recessive mutation in il17ra, and cells from this
patient did not express the receptor and hence were refractory
to IL-17 signaling. Another cohort exhibited an autosomal domi-
nant mutation in IL-17F that prevents signaling through IL-17A,
IL-17F, and the IL-17A/F heterodimer (Puel et al., 2011). In sepa-
rate studies, gain-of-function mutations in the gene encoding
signal transducer and activator of transcription 1 (STAT1) were
identified as causes of CMC disease and were associated with
reduced Th17 frequency (Liu et al., 2011; van de Veerdonk
et al., 2011b). It is not fully clear why this STAT1 mutation causes
CMC and reduced Th17 cell numbers, but STAT1-activating
cytokines such as IFNa/b, IFNg , and IL-27 are all inhibitors of
Th17 differentiation, and therefore Th17 cells appear to be
abnormally restrained in these patients.
In scenarios where CMC is present in conjunction with other
infections and/or inflammatory defects, identifying a single
cause for recurrent candidiasis poses a challenge. Strikingly, in
many cases defects in some component of Th17 differentiation
or the pattern recognition pathways that promote it have been
linked to disease. For example, Hyper IgE (Job’s) Syndrome
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C. albicans infections and exhibit a Th17 deficiency due to domi-
nant negative mutations in stat3 (Ma et al., 2008; Milner et al.,
2008; Minegishi et al., 2007). STAT3 is critical for Th17 differen-
tiation in mice (Chen et al., 2006; Yang et al., 2007), as it lies is
downstream of signaling by IL-23, IL-21, and IL-6 (all involved
in induction and maintenance of Th17 cells) as well as IL-22
(produced by Th17 cells). Although a failure to differentiate
Th17 cells is the most obvious cause of their susceptibility to
Candida, these patients also have impaired antifungal activity
of saliva (Conti et al., 2011), and their keratinocytes show defec-
tive responses to Th17 cytokines (Minegishi et al., 2009).
Mutations in the PRR pathway have also been identified that
cause CMC, reinforcing results from knockout mouse studies.
Some CMC patients show deficiencies in card9 or dectin1.
Notably, the dectin-1 mutation appears to be a polymorphism
found in a population-wide search in individuals from both
Europe and Africa and is associated with increased Candida
colonization in immunosuppressed hematopoietic stem cell
transplant recipients (Ferwerda et al., 2009; Glocker et al.,
2009; Plantinga et al., 2009).
Another cohort of patients with CMC have autoimmune poly-
endocrinopathy syndrome-1 (APS-1), characterized by genetic
defects in central tolerance due to mutations the transcription
factor AIRE (Browne and Holland, 2010). The cause of CMC in
APS-1 was enigmatic, until it was discovered in 2010 that these
patients produce neutralizing autoantibodies against Th17 cyto-
kines, namely IL-17A, IL-17F, and IL-22 (Kisand et al., 2010; Puel
et al., 2010). These observations, together with the fact that the
majority ofC. albicans-specific T cells in human peripheral blood
exhibit a classical Th17 phenotype (Acosta-Rodriguez et al.,
2007), strongly support a crucial role for Th17 cells in immunity
to C. albicans.
Mechanisms of IL-17-Mediated Immunity
Pioneering studies of IL-17 in a Klebsiella pneumoniae infection
model demonstrated that IL-17 is a major inducer of granulopoi-
esis and neutrophil chemotaxis (Ye et al., 2001). A plethora of
studies in other infection systems, many conducted long before
the recognition of Th17 cells, showed that IL-17 mobilizes
neutrophils. IL-17 activates neutrophils indirectly, primarily by
upregulating expression of G-CSF and CXC chemokines in
mucosal epithelial cells as well as the local stroma (Khader
et al., 2009) (Figure 2C). Although IL-17RA is highly expressed
in neutrophils, there is no convincing data showing that IL-17
acts directly on these cells, since neutrophils lack the coreceptor
IL-17RC (Pelletier et al., 2010). With respect to candidiasis, IL-17
appears tomediatemany of its protective effects viamobilization
of neutrophils to peripheral inflammatory sites, although there is
reason to postulate that other antimicrobial mechanisms are also
important. In systemic candidemia, IL-17R-deficient mice ex-
hibited decreased absolute neutrophil counts (ANCs) in periph-
eral blood, which correlated with impaired neutrophil recruitment
and myeloperoxidase (MPO) activity in kidney (Huang et al.,
2004). In OPC, both IL-23p19/ and IL-17R/ mice exhibit
decreased neutrophil numbers in the oral mucosa compared to
resistantmouse strains.Moreover, microarray analysis of tongue
tissue showed induction of prototypical IL-17 target genes that
serve to expand or recruit neutrophils, such as genes encodingCXCL1 (KC, Groa), CXCL2 (MIP2), CXCL5 (LIX), and CSF3 (G-
CSF) (Conti et al., 2009). In addition, C. albicans can stimulate
oral epithelial cells (OECs) to secrete CXCL8 (IL-8), another
potent neutrophil chemoattractant (Dongari-Bagtzoglou and
Kashleva, 2003; Dongari-Bagtzoglou et al., 2005). Similarly, in
a murine model of vulvovaginal candidiasis (VVC), 75% of the
total vaginal infiltrate at 48 hr postinfection were found to be
neutrophils, coinciding with elevated IL-17 and IL-23 in vaginal
fluid (Pietrella et al., 2011). In addition, it has been demonstrated
that b-glucans can induce human neutrophil chemotaxis and
that neutrophil extracellular traps can capture and kill both
C. albicans yeast and hyphae (Urban et al., 2006). Therefore,
IL-17-dependent recruitment of neutrophils to the site of infec-
tion is likely an important element in host responses to
C. albicans.
Despite its potent effects on neutrophils, it is not clear whether
mobilization of neutrophils is the primary underlying mechanism
by which IL-17 mediates antifungal effects. Although patients
undergoing chemotherapy associated with neutropenia are
highly susceptible to various forms of disseminated candidiasis,
individuals with isolated neutropenia or neutrophil defects such
as chronic granulomatous disease (CGD) are not particularly
prone to Candida infections (Del Favero, 2000; Grigull et al.,
2006; Maertens et al., 2001). In this regard, IL-17 induces antimi-
crobial peptide (AMP) expression in a variety of settings, and
many of the IL-17-induced AMPs have direct antifungal activity
toward Candida (Gorr, 2009). In skin, IL-17 signals cooperatively
with IL-22 to induce AMPs such as S100A7 and b-defensin 2
(BD2) in keratinocytes and epithelial cells (Liang et al., 2006). In
humans with HIES, this effect is significantly impaired (Minegishi
et al., 2009), perhaps explaining the susceptibility to dermal
candidiasis in these patients. In VVC, production of BD2 by
vaginal epithelial cells is inhibited after ablation of Th17
responses (Pietrella et al., 2011). Moreover, in murine OPC,
AMPs such as S100A8, S100A9, and b-defensin 3 (murine
homolog of BD2) are induced in tongue in WT mice but impaired
in IL-17R/ animals (Conti et al., 2009). Saliva is another impor-
tant defense mechanism to limit oral candidiasis; notably, saliva
from HIES patients has increased C. albicans colonization and
significantly decreased levels of BD2 and histatins (salivary
AMPs specific to primates) compared to healthy donors.
Furthermore, this study also showed IL-17 could directly
induce histatin expression in human salivary gland acinar cells,
identifying a previously unrecognized target organ for this cyto-
kine (Conti et al., 2011). Thus, IL-17 mediates antifungal host
defense by orchestrating the recruitment of neutrophils to the
site of infection and also by upregulating expression of AMPs
at mucosal surfaces (Figure 2C).
Although there is data implicating IL-17 and/or Th17 cells in
immunity to Candida in various settings, its relative importance
in different anatomic sites is not fully elucidated. As noted,
studies in both humans and mice overwhelmingly support
a role for IL-17 in oral candidiasis, based on susceptibility in
HIV+ patients, IL-17R-deficient and IL-17F-deficient humans
and IL-17R/ and IL-23/ knockout mice (Filler, 2012; Gaffen
et al., 2011). Dermal candidiasis also involves IL-17, based on
mouse studies (Hirota et al., 2011; Igya´rto´ et al., 2011; Kagami
et al., 2010) as well as human CMC syndromes (Table 1). In
disseminated candidemia, IL-17A and IL-17RA/ mice areCell Host & Microbe 11, May 17, 2012 ª2012 Elsevier Inc. 431
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but the data for a nonredundant role for IL-17 in humans is
less compelling. For example, HIV+ individuals and other
Th17-deficient cohorts (e.g., HIES or APS1 patients) do not
routinely experience systemic candidiasis. Instead, systemic
disease is associated only with combined lymphopenia and neu-
tropenia, and CARD9 is the only molecule to date genetically
linked to systemic candidiasis in humans (Glocker and Grim-
bacher, 2010; Glocker et al., 2009). Finally, the role of IL-17 in
vaginal candidiasis is controversial. Although HIV/AIDS patients
do not experience high rates of VVC, HIES patients and Dectin-
1-deficient humans do (Table 1) (reviewed in Freeman and
Holland, 2008; Yano et al., 2012). Somemouse studies implicate
IL-17 in VVC (Pietrella et al., 2011), but others have failed to find
a strong connection (Yano et al., 2012). Thus, IL-17 plays tissue-
specific roles in immunity to C. albicans.
Concluding Remarks and Future Perspectives
The discovery of Th17 cells as a subset distinct from Th1 and Th2
cells has been of paramount importance in understanding
antifungal host defense mechanisms. It is now clear that IL-17-
mediated recruitment of neutrophils and induction of AMPs at
peripheral inflammatory sites are essential for host defense
against Candida albicans, and probably other extracellular
fungal organisms as well. However, the cellular source(s) of IL-
17 production and the niche(s) it occupies during C. albicans
infections in different anatomical sites remain an open and
exciting research topic. Based on the protective roles of IL-23
and IL-17 in most experimental and human C. albicans infec-
tions, it has been generally assumed that ‘‘classical’’
CD4+Th17 cells are responsible for IL-17 production and subse-
quent fungal clearance. This view is supported by the high sensi-
tivity of CD4-depleted HIV/AIDS patients and Th17-deficient
HIES patients to oral thrush. However, in recent years a number
of innate sources of IL-17 have been reported, including NKT, gd
T, macrophage, and innate lymphoid cells (ILCs) (Cua and Tato,
2010). In many settings, these rather than Th17 cells have been
shown to play crucial roles in mucosal immunity. For example, in
dermal candidiasis the gd T cell subsets are critical, at least in
acute infection models (Hirota et al., 2011; Kagami et al.,
2010). Nonetheless, it is clear that immunocompetent humans
mount strong CD4+ Th17 responses to Candida (Acosta-Rodri-
guez et al., 2007), and to date the relative contributions of innate
versus adaptive IL-17 responses in C. albicans infections have
not been well elucidated. This is likely to be an important area
of inquiry in the future, as the integration of innate and adaptive
sources of IL-17 becomes better understood.
Biologic drugs that target inflammatory cytokines have revolu-
tionized treatment of autoimmune diseases such as rheumatoid
arthritis and psoriasis. However, an inevitable risk with these
therapies is infection. Drugs targeting TNFa do not predispose
to Candida infections (Strangfeld and Listing, 2006), consistent
with observations that TNFa/mice are resistant to candidiasis
(Farah et al., 2006). Antibodies targeting IL-17A and IL-17RA are
now in clinical trials to treat various autoimmune conditions
(Genovese et al., 2010; Hueber et al., 2010), and as noted above,
APS-1 patients with naturally occurring neutralizing antibodies
against IL-17 routinely develop CMC (Table 1) (Kisand et al.,
2010; Puel et al., 2010). Although available data have not yet432 Cell Host & Microbe 11, May 17, 2012 ª2012 Elsevier Inc.identified CMC as a major adverse event associated with clinical
application of anti-IL-17 therapies, this is nonetheless a potential
clinical issue that should be monitored.ACKNOWLEDGMENTS
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